The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
Després, J.-P., Golay, A., & Sjöström, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044537 · Cited by 1,392 · cited 1×
“SR141716 potentiated lithium chloride-induced conditioned rejection reactions in rats (Parker et al, 2003), and this drug also produced emesis in the least shrew (Darmani, 2001) and nausea in humans (Despres et al, 2005).”
BackgroundSalamone, J. D., & Correa, M. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00282-6 · Cited by 817
Self-citationAberman, J. E., & Salamone, J. D. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00004-4 · Cited by 263 · cited 5×
“…of other manipulations (eg nucleus accumbens dopamine depletions, dopamine antagonists) has indicated that the ratio requirement of a schedule can be a critical determinant of the effects of various neurochemical or pharmacological manipulations (Aberman and Salamone, 1999; Ishiwari et al, 2004).”
BackgroundResultInfluentialSelf-citation
Cited by
The endocannabinoid system and the brain.
Mechoulam, R., & Parker, L. A. (2013) · Annual Review of Psychology · doi:10.1146/annurev-psych-113011-143739 · Cited by 1,090
“It will be of interest to evaluate the potential of more newly developed CB1 receptor neutral antagonists, such as AM4113 (Sink et al. 2008), to prevent drug-seeking behavior.”
BackgroundSelf-citationTam, J., Vemuri, V. K., Liu, J., Bátkai, S., Mukhopadhyay, B., Godlewski, G., Osei-Hyiaman, D., Ohnuma, S., Ambudkar, S. V., Pickel, J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42551 · Cited by 454
Self-citationCannabinoids and the gut: New developments and emerging concepts
Izzo, A. A., & Sharkey, K. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.12.005 · Cited by 419
Receptors and Channels Targeted by Synthetic Cannabinoid Receptor Agonists and Antagonists
Pertwee, R. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980050 · Cited by 335
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Lowe, H., Toyang, N., Steele, B., Bryant, J., & Ngwa, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179472 · Cited by 303
Metadata
- Authors
- Sink, K. S., McLaughlin, P. J., Wood, J. A. T., Brown, C., Fan, P., Vemuri, V. K., Pang, Y., Olzewska, T., Thakur, G. A., Makriyannis, A., Parker, L. A., & Salamone, J. D.
- Venue
- Neuropsychopharmacology
- Published
- 2007-06-20
- Volume
- 33
- Issue
- 4
- Pages
- 946-955
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2168128112
- Cited by
- 161
- References
- 4
- FWCI
- 8.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats. https://app.cochat.ai/papers/10.1038/sj.npp.1301476
- The paper
- Sink, K. S., McLaughlin, P. J., Wood, J. A. T., Brown, C., Fan, P., Vemuri, V. K., Pang, Y., Olzewska, T., Thakur, G. A., Makriyannis, A., Parker, L. A., & Salamone, J. D. (2008). The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats. Neuropsychopharmacology. https://doi.org/10.1038/sj.npp.1301476
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.